Cipla launches drug to treat H1N1 virus

  MUMBAI (Reuters) – Drug maker Cipla Ltd on Wednesday launched its generic version of Roche’s Tamiflu, used in the treatment of the H1N1 swine flu virus, the firm said in a statement.

 Cipla’s Oseltamivir brand, called Antiflu, will cost 475 rupees for 10 capsules, with 75 ml syrup will be similarly priced.

 Cipla’s drug is also pre-qualified by the World Health Organisation.

  (For more news on Reuters Money visit )







Yahoo! plans to expand, hire people in India – CEO


Yahoo! Inc plans to grow its business in India and hire additional people there, its chief executive Carol Bartz said on Tuesday.

 Bartz, who was speaking at a luncheon in Singapore, said she was heading from the city-state to India where she would meet the country’s prime minister and other senior officials.

 She also said Yahoo! is “happy” with its investment in China’s Alibaba, although it recently sold a small part of its shares in, the Chinese firm’s listed unit.

 (For more news on Reuters Money visit